Home Search

petv - search results

If you're not happy with the results, please do another search

Resuming Coverage on PetVivo (PETV).

After Being up 1,035%, Raising $11 Million, Upgrading to NASDAQ, and Retreating 87% From its High, we Resume Coverage.
Biotech Stock Review

Discontinuing Coverage of PetVivo (PETV), a Gain of 1,035%.

Another 10 Bagger, Bagged. PetVivo (PETV) is a great little business idea - finally ready to open for...
PetVivo, Biotech Stock Review

And Slowly But Surely..We Have Another 10-Bagger. PetVivo (PETV).

Things moving rather swimmingly at Pet-Vivo (PETV). Well, chart-wise. REWARDS GO TO THE PATIENT?

Emerald Organic Products, Inc. (EMOR) Announces Exclusive Licensing Agreement With PetVivo Holdings Inc. (PETV).

New York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) ("Emerald" or the "Company") is pleased to announce...

Biotech Stock Review Adding PetVivo (PETV) $0.23 to the Watch List.

Are We Catching a Falling Knife? Don't Think So! LIVE QUOTE

New to the Street | Newsmax TV | Episode 508

New to the Street 503 | Newsmax TV, Saturday, August 19, 2023 https://youtu.be/0Jd8HOiYx3k?si=DRpuBoot61gfk7nD August...

ThinkEquity Investor Conference (NYC), Wednesday October 26th.

ThinkEquity is a boutique investment bank run by experienced professionals that have worked together for over a...

Latest article

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

Major Mpox Outbreak in the Democratic Republic of Congo.

As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

Mpox Infections Rise to Almost Double Last Year’s Numbers.

The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...